Showing papers by "Leigh T. Canham published in 2002"
Patent•
20 Feb 2002
TL;DR: In this article, an internal therapeutic product consisting of an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug, and a silicon component was presented for the treatment of cancer.
Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.
47 citations
Patent•
20 Dec 2002
TL;DR: A fibre or fabric comprising silicon for use as a medical fiber or fabric is described in this article, where the silicon present can be biocompatible, bio-active or resorbable material and may also act as an electrical conductor.
Abstract: A fibre or fabric comprising silicon for use as a medical fibre or fabric. The silicon present can be biocompatible, bioactive or resorbable material and may also be able to act as an electrical conductor. In addition, porous silicon may be used as a slow release means for example for drugs or fragrances, or as a collector for example for sweat. Novel fibres, fabrics and methods of preparation of these are also described and claimed.
34 citations
25 citations
Patent•
14 Aug 2002
TL;DR: In this paper, attachable body fluid collection devices, each comprising at least one storage structure for, when in use, storing a body fluid sample secreted by a body's secreting surface.
Abstract: The invention relates to attachable body fluid collection devices, each comprising at least one storage structure for, when in use, storing a body fluid sample secreted by a body fluid secreting surface. The or at least one of the storage structure comprises silicon. Particular emphasis is placed on sweat patches and techniques for analyzing sweat.
12 citations
Patent•
20 Dec 2002
TL;DR: A fibre or fabric comprising silicon for use as a medical fiber or fabric is described in this paper, where the silicon present can be biocompatible, bio-active or resorbable material and may also act as an electrical conductor.
Abstract: A fibre or fabric comprising silicon for use as a medical fibre or fabric. The silicon present can be biocompatible, bioactive or resorbable material and may also be able to act as an electrical conductor. In addition, porous silicon may be used as a slow release means for example for drugs or fragrances, or as a collector for example for sweat. Novel fibres, fabrics and methods of preparation of these are also described and claimed.
6 citations
Patent•
20 Feb 2002
TL;DR: In this article, an internal therapeutic product consisting of an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug, and a silicon component was presented for the treatment of cancer.
Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selectedfrom one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.
1 citations
Patent•
20 Feb 2002
Patent•
20 Feb 2002
TL;DR: In this article, a produit therapeutique interne renfermant (i) un composant anti-cancereux selectionne parmi un radionucleotide et/ou un medicament cytotoxique, and (ii) un Composant de silicium selectionn parmi du siliciam resorbable, du sililicium biocompatible, dusilicium bioactif, du SILICium poreux, du Silicium polycristallin, du ISC amorphe et du SIL
Abstract: L'invention concerne le traitement du cancer et plus specialement un produit therapeutique interne renfermant (i) un composant anti-cancereux selectionne parmi un radionucleotide et/ou un medicament cytotoxique, et (ii) un composant de silicium selectionne parmi du silicium resorbable, du silicium biocompatible, du silicium bioactif, du silicium poreux, du silicium polycristallin, du silicium amorphe et du silicium en masse cristallin, le produit therapeutique interne etant destine au traitement du cancer.
Patent•
20 Feb 2002
TL;DR: In this article, an internal therapeutic product consisting of an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug, and a silicon component was presented for the treatment of cancer.
Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.